Literature DB >> 9177154

Rejection antigens in chemically induced tumors.

G Klein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9177154      PMCID： PMC33672          DOI： 10.1073/pnas.94.12.5991

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

1.  Immunosuppressive effects of 3-methylcholanthrene given intratracheally in various inbred strains of mice.

Authors:  R L Levy; M H Barrington; R A Lerner; G F Griffin; C E Whitmire
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

Review 2.  Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture.

Authors:  G Klein
Journal:  Cancer Res       Date:  1968-04       Impact factor: 12.701

3.  Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation.

Authors:  M K Gjertsen; A Bakka; J Breivik; I Saeterdal; B G Solheim; O Søreide; E Thorsby; G Gaudernack
Journal:  Lancet       Date:  1995-11-25       Impact factor: 79.321

4.  Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas.

Authors:  K Kuroda; K Yamashina; N Kitatani; A Kagishima; T Hamaoka; Y Hosaka
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

Review 5.  Identification of tumour rejection antigens recognized by T lymphocytes.

Authors:  T Boon; E De Plaen; C Lurquin; B Van den Eynde; P van der Bruggen; C Traversari; A Amar-Costesec; A Van Pel
Journal:  Cancer Surv       Date:  1992

6.  Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.

Authors:  K Kono; M Petersson; A M Ciupitu; T Wen; G Klein; R Kiessling
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

7.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Authors:  T Wölfel; M Hauer; J Schneider; M Serrano; C Wölfel; E Klehmann-Hieb; E De Plaen; T Hankeln; K H Meyer zum Büschenfelde; D Beach
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

8.  Systemic effects of methylcholanthrene in mice. II. Immune responses to sheep red cells.

Authors:  R Schreiber; K Stern
Journal:  Oncology       Date:  1984       Impact factor: 2.935

9.  Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.

Authors:  M E Dudley; D C Roopenian
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

Authors:  J I Mayordomo; D J Loftus; H Sakamoto; C M De Cesare; P M Appasamy; M T Lotze; W J Storkus; E Appella; A B DeLeo
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307
View more
  1 in total

Review 1.  The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.

Authors:  Christopher V Nicchitta; Deanna M Carrick; Julie C Baker-Lepain
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.